PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+57.5%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$4.47B
AUM Growth
+$4.47B
(+50%)
Cap. Flow
+$491M
Cap. Flow
% of AUM
10.98%
Top 10 Holdings %
Top 10 Hldgs %
48.45%
Holding
116
New
21
Increased
27
Reduced
22
Closed
11
Top Buys
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$81.5M |
| 2 |
CRGX
CARGO Therapeutics
CRGX
|
$79.6M |
| 3 |
Spyre Therapeutics
SYRE
|
$54.4M |
| 4 |
Axsome Therapeutics
AXSM
|
$44.3M |
| 5 |
Biohaven
BHVN
|
$41.7M |
Top Sells
| 1 |
argenx
ARGX
|
$74M |
| 2 |
Immunovant
IMVT
|
$62.6M |
| 3 |
Roivant Sciences
ROIV
|
$44.6M |
| 4 |
Harmony Biosciences
HRMY
|
$32.6M |
| 5 |
Relay Therapeutics
RLAY
|
$16.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Solid Biosciences
SLDB
$448M
| $21.5M | 0.48% |
3,495,933
| – | – |
|
52
Intuitive Surgical
ISRG
$158B
| $18.6M | 0.41% |
+55,000
| New | +$18.6M |
|
53
Artivion
AORT
$2.04B
| $16.7M | 0.37% |
931,352
| – | – |
|
54
Ascendis Pharma
ASND
$12.1B
| $16.6M | 0.37% |
+132,176
| New | +$16.6M |
|
55
Treace Medical Concepts
TMCI
$458M
| $15.9M | 0.36% |
1,250,405
-583,655
| -32% | -$7.44M |
|
56
Mirum Pharmaceuticals
MIRM
$3.75B
| $15.8M | 0.35% |
534,942
-137,100
| -20% | -$4.05M |
|
57
Acrivon Therapeutics
ACRV
$42.2M
| $14.8M | 0.33% |
3,007,858
| – | – |
|
58
Arvinas
ARVN
$580M
| $14.6M | 0.33% |
+354,082
| New | +$14.6M |
|
59
Applied Therapeutics
APLT
$73.7M
| $13.7M | 0.31% |
+4,080,249
| New | +$13.7M |
|
60
EyePoint Pharmaceuticals
EYPT
$827M
| $13.6M | 0.3% |
+589,646
| New | +$13.6M |
|
61
Athira Pharma
ATHA
$15.5M
| $13.1M | 0.29% |
5,402,964
+605,686
| +13% | +$1.47M |
|
|
AUTL
62
Autolus Therapeutics
AUTL
$383M
| $11.8M | 0.26% |
+1,831,167
| New | +$11.8M |
|
63
Zymeworks
ZYME
$1.07B
| $11.2M | 0.25% |
1,074,807
-371,316
| -26% | -$3.86M |
|
64
Tango Therapeutics
TNGX
$745M
| $11M | 0.25% |
1,111,870
-1,307,098
| -54% | -$12.9M |
|
65
Tactile Systems Technology
TCMD
$295M
| $10.1M | 0.23% |
707,159
| – | – |
|
66
Protagonist Therapeutics
PTGX
$3.62B
| $8.79M | 0.2% |
383,260
-671,013
| -64% | -$15.4M |
|
|
ITCI
67
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.73M | 0.17% |
+108,000
| New | +$7.73M |
|
68
Olema Pharmaceuticals
OLMA
$432M
| $7.57M | 0.17% |
+539,831
| New | +$7.57M |
|
69
Terns Pharmaceuticals
TERN
$651M
| $6.98M | 0.16% |
1,075,000
| – | – |
|
70
Cogent Biosciences
COGT
$1.83B
| $6.6M | 0.15% |
1,122,958
-1,186,512
| -51% | -$6.98M |
|
71
Regenxbio
RGNX
$498M
| $6.15M | 0.14% |
+342,408
| New | +$6.15M |
|
72
Edgewise Therapeutics
EWTX
$1.54B
| $6.08M | 0.14% |
+555,555
| New | +$6.08M |
|
73
MacroGenics
MGNX
$121M
| $5.89M | 0.13% |
+611,932
| New | +$5.89M |
|
74
Axogen
AXGN
$718M
| $5.52M | 0.12% |
808,380
-67,518
| -8% | -$461K |
|
|
LABP
75
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $5.44M | 0.12% |
1,486,991
| – | – |
|